Abstract
Müllerian inhibiting substance (MIS) has been shown to inhibit growth of a number of tumors in vitro and/or in vivo, but the downstream pathways which it regulates are not fully understood. In the present study we show that MIS type II receptor was highly expressed in AN3CA cells, a cell line derived from human endometrial cancer cell in which MIS-treatment caused a reduction of cell viability, and induced cellular apoptosis and genes involved cell cycle arrest. To understand the genome-wide effects of MIS on gene regulation, we performed serial gene expression analyses from 0 to 96 h at 24 h intervals after treating AN3CA cells with MIS. Transcriptomic analysis of molecular changes induced by MIS identified 2,688 differentially expressed genes that were significantly up- or down-regulated during the 96 h study period. When the 2,688 differentially expressed genes were mapped to known biological processes, Wnt-, cancer-, proteolysis-, cytoskeleton-, cell cycle-, apoptosis-, and MAPK-signaling pathways emerged as the functions most significantly changed by MIS in AN3CA cells. Furthermore, western blot analysis validated that protein expression of cell cycle inhibitory genes, apoptotic protease activating factor-1 (APAF-1), β-cat...Continue Reading
References
Feb 1, 1983·Gynecologic Oncology·J V Bokhman
Jan 7, 1999·The EMBO Journal·R WisdomC Moore
Aug 26, 2000·The Journal of Biological Chemistry·T U HaS Maheswaran
Dec 13, 2000·Molecular and Cellular Biology·S HinoA Kikuchi
Feb 1, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hans K LorenzoDavid T MacLaughlin
Dec 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thanh U BarbiePatricia K Donahoe
Dec 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Elizabeth J RenaudPatricia K Donahoe
Dec 3, 2005·The Lancet Oncology·Sheetal AcharyaGini F Fleming
Nov 9, 2007·Gynecologic Oncology·Jamie N Bakkum-GamezWilliam A Cliby
Jul 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amit M OzaElizabeth A Eisenhauer
Aug 31, 2011·Obstetrics and Gynecology International·Karim S Elsahwi, Alessandro D Santin
Oct 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian M Slomovitz, Robert L Coleman
Dec 18, 2012·Histopathology·Xavier Matias-Guiu, Jaime Prat
Jan 19, 2013·Pharmacology & Therapeutics·Hoeke A BaarsmaReinoud Gosens
Feb 14, 2013·British Journal of Cancer·N ColomboF Haluska
Feb 26, 2013·Gynecologic Oncology·Kim A H NicolaijeLonneke V van de Poll-Franse
Jul 3, 2013·BioMed Research International·Peixin DongNoriaki Sakuragi
Citations
Jun 28, 2018·The Journal of Clinical Endocrinology and Metabolism·Keun Young CheonJang Heub Kim
Dec 17, 2017·Oncotarget·Houcine BougheraraDidier Decaudin
Jan 27, 2018·Obstetrics & Gynecology Science·Shin Young KimJang Heub Kim
Mar 20, 2019·International Journal of Molecular Sciences·Marek GowkielewiczMarta Majewska
Aug 28, 2020·Reproductive Sciences·Yun-Xing FuFei-Miao Wang
Feb 16, 2017·International Journal of Oncology·Sang Ho ParkJang Heub Kim
Jan 19, 2019·Oncology Letters·Su Mi KimJang Heub Kim
Jan 25, 2020·Theriogenology·Monica M Laronda